Investing.com - Morphosys AG reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Morphosys AG announced earnings per share of €-1.62 on revenue of €18.4M. Analysts polled by Investing.com anticipated EPS of €-1.66 on revenue of €10.5M.
Morphosys AG shares are down 11% from the beginning of the year and are trading at €112.825 , down-from-52-week-high.They are outperforming the STOXX 600 which is down 12.58% from the start of the year.
Morphosys AG follows other major Healthcare sector earnings this month
Morphosys AG's report follows an earnings beat by Bayer on Tuesday, who reported EPS of €2.67 on revenue of €10.05B, compared to forecasts EPS of €1.5 on revenue of €10.57B.
Siemens Healthineers had beat expectations on Monday with third quarter EPS of €0.3 on revenue of €3.31B, compared to forecast for EPS of €0.27 on revenue of €3.36B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar